Is there an association with phosphorylation and dephosphorylation of Src kinase at tyrosine 530 and breast cancer patient disease-specific survival

por Elsberger, B, Tan, B A, Mallon, E A, Brunton, V G, Edwards, J
Publicado 2010

The relationship between lymphocyte subsets and clinico-pathological determinants of survival in patients with primary operable invasive ductal breast cancer

por Mohammed, Z M A, Going, J J, Edwards, J, Elsberger, B, McMillan, D C
Publicado 2013

The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast can...

por Mohammed, Z MA, Going, J J, Edwards, J, Elsberger, B, Doughty, J C, McMillan, D C
Publicado 2012

Expression of sphingosine 1-phosphate receptor 4 and sphingosine kinase 1 is associated with outcome in oestrogen receptor-negative breast cancer

por Ohotski, J, Long, J S, Orange, C, Elsberger, B, Mallon, E, Doughty, J, Pyne, S, Pyne, N J, Edwards, J
Publicado 2012

Expression of sphingosine 1-phosphate receptor 4 and sphingosine kinase 1 is associated with outcome in oestrogen receptor negative breast cancer

por Ohotski, J, Long, J S, Orange, C, Elsberger, B, Mallon, E, Doughty, J, Pyne, S, Pyne, N J, Edwards, J
Publicado 2012

Is the biology of breast cancer changing? A study of hormone receptor status 1984–1986 and 1996–1997

por Brown, S B F, Mallon, E A, Edwards, J, Campbell, F M, McGlynn, L M, Elsberger, B, Cooke, T G
Publicado 2009

Breast cancer patients’ clinical outcome measures are associated with Src kinase family member expression

por Elsberger, B, Fullerton, R, Zino, S, Jordan, F, Mitchell, T J, Brunton, V G, Mallon, E A, Shiels, P G, Edwards, J
Publicado 2010

Comparison of Visual and automated assessment of Ki-67 proliferative activity and their impact on outcome in primary operable invasive ductal breast cancer

por Mohammed, Z M A, McMillan, D C, Elsberger, B, Going, J J, Orange, C, Mallon, E, Doughty, J C, Edwards, J
Publicado 2012